|thrombosis clinic calgary||0.16||0.5||6023||56|
|thrombosis clinic edmonton||0.4||0.1||1341||88|
|thrombosis clinic oakville||0.95||0.9||9990||25|
|thrombosis clinic ottawa||0.66||0.3||4147||46|
|thrombosis clinic st catharines||1.48||0.9||4544||87|
|thrombosis clinic rah||1.93||0.1||5740||55|
|thrombosis clinic near me||0.83||1||4671||69|
|thrombosis clinic referral||1.74||0.3||3441||20|
|thrombosis clinic toronto general||1.4||0.3||1915||16|
|thrombosis clinic richmond road||0.13||0.1||496||35|
|thrombosis clinic referral form||1.66||1||3361||14|
|thrombosis clinic uhn||1.22||0.5||8153||64|
|thrombosis clinic tgh||0.97||0.9||9717||58|
Chronic lymphocytic leukemia presenting with extreme hyperleukocytosis and thrombosis of the common femoral vein Very few case reports dealing with chronic lymphocytic leukemia (CLL) and hyperleukocytosis have been reported in the medical literature and none with venous thrombosis as a complication.What is the prognosis of venous thromboembolism in chronic lymphocytic leukemia?
Venous thromboembolism (VTE) is a major cause of morbidity and mortality in patients (pts) with malignant tumors. Increased risk of VTE is well described in a variety of hematologic malignancies; however, data regarding VTE in chronic lymphocytic leukemia (CLL) is very limited.Does CLL play a role in the development of ventricular tachycardia (VTE)?
Based on our results, VTE is a relatively frequent complication in patients with CLL. Although most patients had other known risk factors for VTE including CLL treatment, 29% had no risk factors or only age ≥ 60 years. These findings demonstrate the possible role of CLL in the development of VTE.How common is vascular thrombocytopenic purpura (VTE) in patients with CLL?
Our data show that VTE is a relatively frequent complication in patients with CLL. The incidence of VTE in CLL patients is comparable to the other hematological malignancies.